Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study).

Stefano KimMarine JaryThierry AndréVéronique VendrelyBruno BuecherEric FrançoisFrançois-Clément BidardSarah DumontEmmanuelle SamalinDidier PeiffertSimon PernotNabil Baba-HamedFarid El HajbiOlivier BouchéJérôme DesrameAurélie ParzyMustapha ZoubirChristophe LouvetJean-Baptiste BachetThierry NguyenMeher Ben AbdelghaniDenis SmithChristelle De La FouchardièreThomas AparicioJaafar BennounaJean-Marc GornetMarion JacquinFranck BonnetainChristophe Borg

Published in: BMC cancer (2017)

NCT02402842 , EudraCT: 2014-001789-81.

Keyphrases

locally advanced
phase ii study
squamous cell carcinoma
rectal cancer
radiation therapy
high grade
lymph node metastasis
small cell lung cancer
open label
randomized controlled trial
liver metastases
double blind